-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Precigen, Raises Price Target to $12

Benzinga·11/05/2026 14:34:52
Listen to the news
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $11 to $12.